Bimodal plasma metabolomics strategy identifies novel inflammatory metabolites in inflammatory bowel diseases

Discovery Medicine

Volumn 18, Issue 98, 2014, Pages 113-124

  Yau, Yunki Y ^a,b   Leong, Rupert W L ^a,c   Shin, Sean ^a   Bustamante, Sonia ^b   Pickford, Russell ^b   Hejazi, Leila ^b   Campbell, Beth ^b   Wasinger, Valerie C ^b  

^a ANZAC Research Institute   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c BANKSTOWN LIDCOMBE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II [3-8]; DIPHTHAMIDE; GANGLIOSIDE GM3; KYNURENINE; PICOLINIC ACID; QUINOLINIC ACID; UNCLASSIFIED DRUG; ANGIOTENSIN II; ANGIOTENSIN II, DES-ASP(1)-DES-ARG(2)-ILE(5)-; AUTACOID; HISTIDINE; PICOLINIC ACID DERIVATIVE;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; HUMAN; IMMUNOMODULATION; INFLAMMATORY BOWEL DISEASE; LIQUID CHROMATOGRAPHY; MALE; MASS FRAGMENTOGRAPHY; METABOLITE; METABOLOME; METABOLOMICS; PHENOTYPE; QUANTITATIVE ANALYSIS; ULCERATIVE COLITIS; ANALOGS AND DERIVATIVES; BLOOD; CASE CONTROL STUDY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PILOT STUDY; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

ADULT; ANGIOTENSIN II; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; G(M3) GANGLIOSIDE; HISTIDINE; HUMANS; INFLAMMATION MEDIATORS; INFLAMMATORY BOWEL DISEASES; KYNURENINE; MALE; METABOLIC NETWORKS AND PATHWAYS; METABOLOME; METABOLOMICS; MIDDLE AGED; PICOLINIC ACIDS; PILOT PROJECTS; QUINOLINIC ACID; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 84933035783     PISSN: 15396509     EISSN: 19447930     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ayada K, Yokota K, Kawahara Y, Yamamoto Y, Hirai K, Inaba T, Kita M, Okada H, Yamamoto K, Oguma K. Immune reactions against elongation factor 2 kinase: specific pathogenesis of gastric ulcer from Helicobacter pylori infection. Clin Dev Immunol 2009(10):850623, 2009.
2. Bickel DR. Simple estimators of false discovery rates given as few as one or two p-values without strong parametric assumptions. Stat Appl Genet Mol Biol 21:1-15, 2013.
3. Ciorba MA. Indoleamine 2,3 dioxygenase in intestinal disease. Curr Opin Gastroenterol 29(2):146-152, 2013.
4. Crews B, WikoffWR, Patti GJ, Woo HK, Kalisiak E, Heideker J, Siuzdak G. Variability analysis of human plasma and cerebral spinal fluid reveals statistical significance of changes in mass spectrometry-based metabolomics data. Anal Chem 81(20):8538-8544, 2009.
5. Damjanovich L, Volko J, Forgacs A, Hohenberger W, Bene L. Crohn's disease alters MHC-rafts in CD4+ T-cells. Cytometry A 81(2):149-164, 2012.
6. Fallarino F, Grohmann U, Vacca C, Bianchi R, Orabona C, Spreca A, Fioretti MC, Puccetti P. T cell apoptosis by tryptophan catabolism. Cell Death Differ 9(10):1069-1077, 2002.
7. Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, Ferrara GB. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2, 3-dioxygenase. J Exp Med 196:459-468, 2002.
8. Gall WE, Beebe K, Lawton KA, Adam KP, Mitchell MW, Nakhle PJ, Ryals JA, Milburn MV, Nannipieri M, Camastra S, Natali A, Ferrannini E. alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS One 5(5):e10883, 2010.
9. Garg M, Angus PW, Burrell LM, Herath C, Gibson PR, Lubel JS. Review article: the pathophysiological roles of the renin-angiotensin system in the gastrointestinal tract. Aliment Pharmacol Ther 35(4):414-428, 2012.
10. Greganova E, Altmann M, Butikofer P. Unique modifications of translation elongation factors. Febs J 278(15):2613-2624, 2011.
11. Hashimoto T, Perlot T, Rehman A, Trichereau J, Ishiguro H, Paolino M, Sigl V, Hanada T, Hanada R, Lipinski S, Wild B, Camargo SM, Singer D, Richter A, Kuba K, Fukamizu A, Schreiber S, Clevers H, Verrey F, Rosenstiel P, et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature 487(7408):477-481, 2012.
12. Johnson JM, Yu T, Strobel FH, Jones DP. A practical approach to detect unique metabolic patterns for personalized medicine. Analyst 135(11):2864-2870, 2010.
13. Kushawaha PK, Gupta R, Sundar S, Sahasrabuddhe AA, Dube A. Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-gamma and IL-12 response in cured Leishmania-infected patients/hamsters and protects hamsters against Leishmania challenge. J Immunol 187(12):6417-6427, 2011.
14. Medana IM, Day NP, Salahifar-Sabet H, Stocker R, Smythe G, Bwanaisa L, Njobvu A, Kayira K, Turner GD, Taylor TE, Hunt NH. Metabolites of the kynurenine pathway of tryptophan metabolism in the cerebrospinal fluid of Malawian children with malaria. J Infect Dis 188(6):844-849, 2003.
15. Miklavcic JJ, Schnabl KL, Mazurak VC, Thomson AB, Clandinin MT. Dietary ganglioside reduces proinflammatory signaling in the intestine. J Nutr Metab 2012:280286, 2012.
16. Mishur RJ, Rea SL. Applications of mass spectrometry to metabolomics and metabonomics: detection of biomarkers of aging and of age-related diseases. Mass Spectrom Rev 31(1):70-95, 2012.
17. Miyake M, Gomes Giacoia E, Aguilar Palacios D, Rosser CJ. Sarcosine, a biomarker for prostate cancer: ready for prime time? Biomark Med 6(4):513-514, 2012.
18. Nagafuku M, Okuyama K, Onimaru Y, Suzuki A, Odagiri Y, Yamashita T, Iwasaki K, Fujiwara M, Takayanagi M, Ohno I, Inokuchi J. CD4 and CD8 T cells require different membrane gangliosides for activation. Proc Natl Acad Sci U S A 109(6):E336-E342, 2012.
19. Opitz CA, Wick W, Steinman L, Platten M. Tryptophan degradation in autoimmune diseases. Cell Mol Life Sci 64(19-20):2542-2563, 2007.
20. Osborn MP, Park Y, Parks MB, Burgess LG, Uppal K, Lee K, Jones DP, Brantley MA Jr. Metabolome-wide association study of neovascular age-related macular degeneration. PLoS One 8(8):e72737, 2013.
21. Pan Z, Raftery D. Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics. Anal Bioanal Chem 387(2):525-527, 2007.
22. Patti GJ, Yanes O, Siuzdak G. Innovation: metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol 13(4):263-269, 2012.
23. Rolsma MD, Kuhlenschmidt TB, Gelberg HB, Kuhlenschmidt MS. Structure and function of a ganglioside receptor for porcine rotavirus. J Virol 72(11):9079-9091, 1998.
24. Schurr A, West CA, Rigor BM. Neurotoxicity of quinolinic acid and its derivatives in hypoxic rat hippocampal slices. Brain Res 568(1-2):199-204, 1991.
25. Shibasaki Y, Mori Y, Tsutumi Y, Masaki H, Sakamoto K, Murasawa S, Maruyama K, Moriguchi Y, Tanaka Y, Iwasaka T, Inada M, Matsubara H. Differential kinetics of circulating angiotensin IV and II after treatment with angiotensin II type 1 receptor antagonist and their plasma levels in patients with chronic renal failure. Clin Nephrol 51(2):83-91, 1999.
26. Storr M, Vogel HJ, Schicho R. Metabolomics: is it useful for inflammatory bowel diseases? Curr Opin Gastroenterol 29(4):378-383, 2013.
27. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 117(3):514-521, 2007.
28. Tautenhahn R, Cho K, Uritboonthai W, Zhu Z, Patti GJ, Siuzdak G. An accelerated workflow for untargeted metabolomics using the METLIN database. Nat Biotechnol 30(9):826-828, 2012.
29. Terness P, Bauer TM, Rose L, Dufter C, Watzlik A, Simon H, Opelz G. Inhibition of allogeneic T cell proliferation by indoleamine 2, 3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med 196:447-457, 2002.
30. Weizman AV, Silverberg MS. Have genomic discoveries in inflammatory bowel disease translated into clinical progress? Curr Gastroenterol Rep 14(2):139-145, 2012.
31. Wolf AM, Wolf D, Rumpold H, Moschen AR, Kaser A, Obrist P, Fuchs D, Brandacher G, Winkler C, Geboes K, Rutgeerts P, Tilg H. Overexpression of indoleamine 2, 3-dioxygenase in human inflammatory bowel disease. Clin Immunol 113:47-55, 2004.